Evaluating the Impact of Enteral Glutamine Supplementation on Preventing Ventilator-Associated Pneumonia: A Pilot Randomized Clinical Trial in Critically Ill Patients
Abstract
Background: Ventilator-associated pneumonia (VAP) is a common and serious complication of mechanical ventilation in intensive care units (ICUs). The current study evaluates the effectiveness of enteral glutamine (GLN) supplementation in preventing VAP in ICU patients.
Methods: This controlled, randomized clinical trial was performed on mechanically ventilated ICU patients who had a Clinical Pulmonary Infection Score (CPIS) of ≤ 6 within 48 hours of starting ventilation. Patients in the intervention group received 40 g of GLN during the first 48 hours after intubation, and this was continued for seven days. Both the intervention and control groups received standard preventive care. Outcomes were evaluated by comparing the incidence of VAP, the number of pneumonia-free days, and the duration of ventilation and ICU length of stay in each group.
Results: We analyzed the medical records of 613 patients to identify those who met the eligibility criteria for our study, resulting in a final cohort of 35 participants (16 in the intervention group and 19 in the control group). The present clinical trial did not reach its target sample size of 23 patients per group, primarily because of participant attrition and loss to follow-up. Our findings revealed no significant differences in the incidence of early, late, or overall VAP between the two groups. However, the number of pneumonia-free days was significantly higher in the intervention group compared to the control group (log-rank test: P-value= 0.05). Other secondary outcomes, such as mortality rate, and the duration of ICU stay, hospital stay, and mechanical ventilation, also showed no significant differences between the two groups.
Conclusion: The administration of oral GLN supplements has been associated with an increase in the number of pneumonia-free days among ICU patients; however, this benefit does not appear to reduce the incidence of VAP. Further high-quality studies are warranted to validate these observations and to investigate the potential efficacy of GLN supplementation within specific patient cohorts.
Silva PL, Rocco PRM. The basics of respiratory mechanics: ventilator-derived parameters. Ann Transl Med. 2018;6(19):1-11.
Atashi V, Yousefi H, Mahjobipoor H, Bekhradi R, Yazdannik A. Effect of oral care program on prevention of ventilator-associated pneumonia in intensive care unit patients. Iran J Nurs Midwifery Res. 2018;23(6):486-90.
Aykac K, Ozsurekci Y, Basaranoglu ST. Future directions and molecular basis of ventilator associated pneumonia. Can Respir J. 2017;2017:2614602.
Rouzé A, Jaillette E, Poissy J, Préau S, Nseir S. Tracheal tube design and ventilator-associated. Pneumonia Respir Care. 2017;62(10):1316-23.
Papazian L, Klompas M, Luy C. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 2020;46(5):888-906.
Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF. Treatment of severe hospital-acquired and ventilator-associated neumonia: a systematic review of inclusion and judgment criterial used in randomized controlled trials. Crit Care. 2017; 21(1):162.
Cotoia A, Spadaro S, Gambetti G, Koulenti D, Cinnella G. Pathogenesis-targeted preventive strategies for multidrug resistant ventilator-associated pneumonia. Microorganisms. 2020;8(6):1-18.
Feng DY, Zhou YQ, Zhou M, Zou XL, Wang YH, Zhang TT. Risk factors for mortality due to ventilator-associated pneumonia in a chinese hospital: a retrospective study. Med Sci Monit. 2019;25:7660-5.
Labeau SO, Van de Vyver K, Brusselaers N, Vogelaers D, Blot SI. Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. Lancet Infect Dis. 2011;11(11):845-54.
Fernández-Barat L, López-Aladid R, Torres A. Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome. EBioMedicine. 2020;60:102995.
Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, et al. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. The Lancet Respiratory Medicine. 2019;7(8):710-20.
McRae MP. Therapeutic benefits of glutamine:An umbrella review of meta-analyses. Biomed Rep. 2017;6(5):576-84.
Stehle P, Kuhn KS. Glutamine: An obligatory parenteral nutrition substrate in critical care therapy. Biomed Res Int. 2015;2015:545467.
Wernerman J. Glutamine supplementation. Ann Intensive Care. 2011;1(1):25.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med. 2013;41(2):580-637.
Aydoğmuş MT, Tomak Y, Tekin M, Katı İ, Hüseyinoğlu Ü. Glutamine supplemented parenteral nutrition to preventventilator-associated pneumonia in the intensive care unit. Balkan Med J. 2012;29(4):414-8.
Estívariz CF, Griffith DP, Luo M, Szeszycki EE, Bazargan N, Dave N, et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. JPEN J Parenter Enteral Nutr. 2008;32(4):389-402.
Aboelmagd R, Moez K, Salem W. Role of parenteral glutamine supplementation on patient outcome in the surgical ICU. Crit Care. 2009;13(1):P136.
Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489-97.
Andrews PJD, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011;342:d1542.
Ziegler TR, May AK, Hebbar G, Easley KA, Griffith DP, Dave N, et al. Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial. Ann Surg. 2016;263(4):646-55.
Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014;18(2):R76.
Pimentel RFW, Fernandes SL. Effects of parenteral glutamine in critically ill surgical patients: a systematic review and meta-analysis. Nutr Hosp. 2020;34(3):616-21.
Apostolopoulou A, Haidich AB, Kofina K, Manzanares W, Bouras E, Tsaousi G, et al. Effects of glutamine supplementation on critically ill patients: Focus on efficacy and safety. An overview of systematic reviews. Nutrition. 2020;78:110960.
van Zanten AR, Dhaliwal R, Garrel D, Heyland DK. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care. 2015;19(1):294.
Yeh CL, Su LH, Wu JM, Yang PJ, Lee PC, Chen PD, et al. Effects of the Glutamine Administration on T Helper Cell Regulation and Inflammatory Response in Obese Mice Complicated with Polymicrobial Sepsis. Mediators Inflamm. 2020;10;2020:8869017.
Stehle P, Ellger B, Kojic D, Feuersenger A, Schneid C, Stover J, et al. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials. Clinical Nutrition ESPEN. 2017;17:75-85.
Liang B, Su J, Chen J, Shao H, Shen L, Xie B. Glutamine enteral therapy for critically ill adult patients: An updated meta-analysis of randomized controlled trials and trial sequential analysis. Clin Nutr. 2024;43(1):124-33.
Frondelius T, Atkova I, Miettunen J, Rello J, Jansson MM. Diagnostic and prognostic prediction models in ventilator-associated pneumonia: Systematic review and meta-analysis of prediction modelling studies. J Crit Care. 2022;67:44-56.
Ben Lakhal H, M’Rad A, Naas T, Brahmi N. Antimicrobial susceptibility among pathogens isolated in early- versus late-onset ventilator-associated pneumonia. Infect Dis Rep. 2021;13(2):401-10.
Batra P, Soni KD, Mathur P. Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials. J Intensive Care. 2020;8(81).
Gu WJ, Wei CY, Yin RX. Lack of Efficacy of Probiotics in Preventing Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. CHEST. 2012;142(4):859-68.
Weng H, Li J-G, Mao Z, Feng Y, Wang C-Y, Ren X-Q, et al. Probiotics for preventing ventilator-associated pneumonia in mechanically ventilated patients: a meta-analysis with trial sequential analysis. Front Pharmacol. 2017;8(717).
Póvoa FCC, Cardinal-Fernandez P, Maia IS, Reboredo MM, Pinheiro BV. Effect of antibiotics administered via the respiratory tract in the prevention of ventilator-associated pneumonia: A systematic review and meta-analysis. J Crit Care. 2018;43:240-5.
Zha S, Niu J, He Z, Fu W, Huang Q, Guan L, et al. Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis. Eur J Med Res. 2023;28(1):348.
Shah AM, Wang Z, Ma J. Glutamine metabolism and its role in immunity, a comprehensive review. Animals (Basel). 2020; 10(2):326..
Sun Y, Zhu S, Li S, Liu H. Glutamine on critical-ill patients: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(2):1503-20.
| Issue | Vol 13, No 3 (Summer 2025) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/jpc.v13i3.20322 | |
| Keywords | ||
| Pneumonia Intensive Care Unit Ventilator-Associated Glutamine | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
